🔗 Share this article

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.

Several experts said the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Service Response and Material Removal

Based on the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The organization said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also discovered communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.

After moments of entering one group, a seller shared WhatsApp details, where most purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Information and Pricing

Within these communities, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how much time a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to possibly significant health risks”.